Page last updated: 2024-08-21

pyrimidine and r 121919

pyrimidine has been researched along with r 121919 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bozigian, H; Chen, C; Chen, TK; Grigoriadis, DE; Huang, CQ; Liu, XJ; McCarthy, JR; Saunders, J; Webb, TR; Wilcoxen, KM; Xie, YF; Zhu, YF	1

Other Studies

1 other study(ies) available for pyrimidine and r 121919

Article	Year
Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. Journal of medicinal chemistry, 2004, Sep-09, Volume: 47, Issue:19 Topics: Adrenocorticotropic Hormone; Animals; Corticotropin-Releasing Hormone; Cyclic AMP; Drug Design; Inhibitory Concentration 50; Male; Mice; Molecular Structure; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship	2004

Article

Year

Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.

Journal of medicinal chemistry, 2004, Sep-09, Volume: 47, Issue:19

Topics: Adrenocorticotropic Hormone; Animals; Corticotropin-Releasing Hormone; Cyclic AMP; Drug Design; Inhibitory Concentration 50; Male; Mice; Molecular Structure; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship

2004